1. Britton WJ, Lockwood DNJ. Leprosy Lancet, 2004; 363(9416): 1209–1219, https://doi.org/10.1016/S0140-6736(0415952-7.
2. Ridley DS, Jopling WH. Classification of leprosy according to immunity: a five group system. Int J Lepr, 1966; 34(3): 255–273.
3. Becx-Bleumink M, Berhe D. Occurrence of reactions, their diagnosis and management in leprosy patients treated with multidrug therapy; experience in the leprosy control program of the All Africa Leprosy and Rehabilitation Training Center (ALERT) in Ethiopia. Int J Lepr Other Mycobact Dis, 1992; 60(2): 173–184.
4. Kumar B, Dogra S, Kaur I. Epidemiological characteristics of Leprosy reactions: 15 years’ experience from North India. Int J Lepr, 2004; 72(2): 125–133.
5. Geluk A, van Meijgaarden KE, Wilson LLongitudinal immune responses and gene expression profiles in type 1 leprosy reactions. J Clin Immunol, 2014; 34(2): 245–255, doi:10.1007/s10875-013-9979-x.